- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06689800
La oss bli EKTE: Kommunikasjonsverktøy for familiehelse innen pediatrisk stamcelletransplantasjon og celleterapi
La oss bli EKTE: En pilotforsøk av et familiehelsekommunikasjonsverktøy innen pediatrisk stamcelletransplantasjon og celleterapi
The investigators will conduct a pilot feasibility and efficacy trial of a newly developed family health communication tool (called Let's Get REAL) in increasing youth involvement in real-time stem cell transplant and cellular therapy decisions (SCTCT). The investigators will pilot the intervention among 24 youth and their parents, stratified by youth age (stratum 1, 8-12 years of age and stratum 2, 13-17 years of age).
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Ginny L Schulz, Ph.D., RN, CPNP-PC
- Telefonnummer: 314-454-6018
- E-post: schulz_g@wustl.edu
Studiesteder
-
-
Missouri
-
St Louis, Missouri, Forente stater, 63110
- Rekruttering
- Washington University School of Medicine
-
Underetterforsker:
- Shalini Shenoy, M.D.
-
Ta kontakt med:
- Ginny L Schulz, Ph.D., RN, CPNP-PC
- Telefonnummer: 314-454-6018
- E-post: schulz_g@wustl.edu
-
Hovedetterforsker:
- Ginny L Schulz, Ph.D., RN, CPNP-PC
-
Underetterforsker:
- Amy McQueen, Ph.D.
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria Youth:
- Children or adolescents 8-17 years of age referred for SCTCT.
- Diagnosis of malignant or nonmalignant disorder.
- Referred for any type of SCTCT. Autologous and allogeneic stem cell and cellular therapies are eligible.
- Planning to meet with a provider to discuss SCTCT.
- Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed assent document.
- Must speak English and be cognitively able to participate.
Inclusion Criteria Parents:
- Parent or guardian of a child 8-17 years of age with any diagnosis referred for any type of SCTCT. Diagnoses may include malignant and nonmalignant disorders. Autologous and allogeneic stem cell and cellular therapies are eligible. Parent or guardian is defined as an adult who usually cares for the youth and has authority to make medical decisions for them.
- Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed consent document.
- Must speak English and be cognitively able to participate.
Exclusion Criteria Youth:
-
Active medical problems severe enough to preclude study participation at the time of recruitment.
- Patients who are otherwise eligible, but whose primary transplant physician does not want them to participate in the study.
-
Lacks cognitive capacity to complete study activities, as determined by consenting professional.
Exclusion Criteria Parents:
- Their youth referred for SCTCT does not assent to participate.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Let's Get REAL family health communication tool: Patients (8-12 years of age)
Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation. |
Family health communication tool |
|
Eksperimentell: Let's Get REAL family health communication tool: Patients (13-17 years of age)
Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation. |
Family health communication tool |
|
Eksperimentell: Let's Get REAL family health communication tool: Parents
Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation. |
Family health communication tool |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Feasibility of intervention as measured by the Feasibility of Intervention questionnaire
Tidsramme: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Acceptability of intervention as measured by the Acceptability of Intervention questionnaire
Tidsramme: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Appropriateness of intervention as measured by the Intervention of Appropriateness questionnaire
Tidsramme: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Feasibility of intervention as measured qualitatively
Tidsramme: Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of feasibility content codes. |
Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
|
Acceptability of intervention as measured qualitatively
Tidsramme: Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of acceptability content codes. |
Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
|
Appropriateness of intervention as measured qualitatively
Tidsramme: Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of appropriateness content codes. |
Up to 8 weeks after SCTCT consultation (estimated to be week 16)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Antall pasienter som valgte SCTCT
Tidsramme: Inntil 4 uker etter SCTCT-konsultasjon (estimert til uke 8)
|
Inntil 4 uker etter SCTCT-konsultasjon (estimert til uke 8)
|
|
|
Difference in feasibility scores in those 8-12 years of age and those 13-17 years of age as measured by the Feasibility of Intervention questionnaire
Tidsramme: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Difference in acceptability scores in those 8-12 years of age and those 13-17 years of age as measured by the Acceptability of Intervention questionnaire
Tidsramme: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Difference in appropriateness scores in those 8-12 years of age and those 13-17 years of age as measured by the Intervention of Appropriateness questionnaire
Tidsramme: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Perceived levels of decision-making involvement in youth 8-17 years of age and their parents as measured by the Decision Making Involvement Scale
Tidsramme: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 30-item scale that youth and their parents report youth involvement behaviors in a decision related to their illness on a 4-point Likert scale ranging from 'A Little Bit' to 'A Lot'. The higher the subscale score (child seek, child express, parent seek, parent express, and joint/options), the more that behavior or type of involvement occurred in the decision making process. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Observed levels of decision-making involvement in youth 8-17 years of age and their parents
Tidsramme: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
Number of utterance occurrences for the following: 1) who uttered (youth, parent), 2) was utterance prompted (yes/no), if so, by who, 3) type of utterance (questions, opinion, concern, other), and 4) content of utterance (prognosis, side effect, expectation). |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Change in youth-parent communication as measured by the Likert-type Parent-Adolescent Communication Scale
Tidsramme: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
This is a 20-item scale that youth and parents report the degree of openness in family communication and the extent of problems with family communications on a 5-point Likert ranging from 'strongly disagree' to 'strongly agree'. A higher score on the degree of openness subscale indicates better communication between parent and adolescent. For extent of problems subscale, a higher score indicates more problems in the parent-child communication. |
Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
|
Change in the level of youth's general anxiety as measured by the Likert-type PROMIS Anxiety 8a Short Form or parent proxy
Tidsramme: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
This is an 8-item scale that measures youth's general anxiety in those 8-17 years of age on a 5-point Likert scale ranging from 'never' to 'almost always'. |
Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
|
|
Level of decisional conflict as measured by the Likert-type Decisional Conflict Scale
Tidsramme: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a 10-item scale that youth and parents report their personal uncertainty and decisional conflict related to a specific decision. We are using the question format as it is recommended for those with limited reading or response skills. They respond 'Yes', 'No, or 'Unsure'. A total decision conflict score ranges from 0 (no decisional conflict) to 100 (extremely high decision conflict). Higher scores on subscales uncertainty, informed, values clarity, and support reflect feeling extremely uncertain about the best choice, feeling extremely uninformed, feeling extremely unclear about personal values, and feeling extremely unsupported in decision making respectively. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Youth-parent congruence of youth decision making involvement as measured by two Likert type statements
Tidsramme: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
Number of dyads that agree on these two statements measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot': 1)"I/my child should be involved in future talks about transplant" and 2) "I/my child wants to be involved in future talks about transplant". |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
|
Satisfaction with the decision making involvement as measured by one Likert type statement
Tidsramme: Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
This is a one item statement, "I am satisfied with my/my child's involvement in the transplant decision making process", measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot'. A higher score indicates more satisfaction. |
Up to 4 weeks after SCTCT consultation (estimated to be week 8)
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Ginny Schulz, Ph.D., RN, CPNP-PC, Washington University School of Medicine
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Benmargssviktforstyrrelser
- Neoplasmer etter nettsted
- Neoplasmer
- Genetiske sykdommer, medfødte
- Sykdommer i immunsystemet
- Hematologiske sykdommer
- Benmargssykdommer
- Anemi, hemolytisk, medfødt
- Anemi, hemolytisk
- Anemi
- Hemoglobinopatier
- Medfødte, arvelige og neonatale sykdommer og abnormiteter
- Ernæringsmessige og metabolske sykdommer
- Hemic og lymfatiske sykdommer
- Hematologiske neoplasmer
- Anemi, sigdcelle
- Immunologiske mangelsyndromer
- Metabolske sykdommer
- Anemi, aplastisk
Andre studie-ID-numre
- 202410119
- K12CA167540 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .